Literature DB >> 19584839

A close look at acid reflux drugs points to possible risks.

Alisa Opar.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19584839     DOI： 10.1038/nm0709-710

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

Review 1.  Rebound hypersecretion after inhibition of gastric acid secretion.

Authors:  Gunnar Qvigstad; Helge Waldum
Journal:  Basic Clin Pharmacol Toxicol       Date:  2004-05       Impact factor: 4.080

2.  Long-term proton pump inhibitor therapy and risk of hip fracture.

Authors:  Yu-Xiao Yang; James D Lewis; Solomon Epstein; David C Metz
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

3.  Impaired gastric acidification negatively affects calcium homeostasis and bone mass.

Authors:  Thorsten Schinke; Arndt F Schilling; Anke Baranowsky; Sebastian Seitz; Robert P Marshall; Tilman Linn; Michael Blaeker; Antje K Huebner; Ansgar Schulz; Ronald Simon; Matthias Gebauer; Matthias Priemel; Uwe Kornak; Sandra Perkovic; Florian Barvencik; F Timo Beil; Andrea Del Fattore; Annalisa Frattini; Thomas Streichert; Klaus Pueschel; Anna Villa; Klaus-Michael Debatin; Johannes M Rueger; Anna Teti; Jozef Zustin; Guido Sauter; Michael Amling
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

4.  Use of proton pump inhibitors and risk of osteoporosis-related fractures.

Authors:  Laura E Targownik; Lisa M Lix; Colleen J Metge; Heather J Prior; Stella Leung; William D Leslie
Journal:  CMAJ       Date:  2008-08-12       Impact factor: 8.262

5.  Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

Authors:  D Gillen; A A Wirz; J E Ardill; K E McColl
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682
  5 in total
  1 in total

1.  The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.

Authors:  T D Barrett; G Lagaud; P Wagaman; J M Freedman; W Yan; L Andries; M C Rizzolio; M F Morton; N P Shankley
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.